Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Inhibition of spleen tyrosine kinase attenuates IgE-mediated airway contraction and mediator release in human precision cut lung slices.

Authors: Koziol-White, Cynthia J; Jia, Yanlin; Baltus, Gretchen A; Cooper, Philip R; Zaller, Dennis M; Crackower, Michael A; Sirkowski, Erich E; Smock, Steven; Northrup, Alan B; Himes, Blanca E; Alves, Stephen E; Panettieri Jr, Reynold A

Published In Br J Pharmacol, (2016 11)

Abstract: Asthma presents as a heterogeneous syndrome characterized by airway obstruction, inflammation and hyper-reactivity (AHR). Spleen tyrosine kinase (Syk) mediates allergen-induced mast cell degranulation, a central component of allergen-induced inflammation and AHR. However, the role of Syk in IgE-mediated constriction of human small airways remains unknown. In this study, we addressed whether selective inhibition of Syk attenuates IgE-mediated constriction and mast cell mediator release in human small airways.Human precision cut lung slices (hPCLS) ex vivo derived from non-asthmatic donors were incubated overnight with human IgE, dexamethasone, montelukast, antihistamines or a selective Syk inhibitor (SYKi). High-affinity IgE receptor (FcεRI) activation by anti-IgE cross-linking was performed, and constriction and mediator release measured. Airway constriction was normalized to that induced by maximal carbachol stimulation. Syk expression (determined by qPCR and immunoblot) was also evaluated in human primary airway smooth muscle (HASM) cells to determine whether Syk directly modulates HASM function.While dexamethasone had little effect on FcεR-mediated contraction, montelukast or antihistamines partially attenuated the response. SYKi abolished anti-IgE-mediated contraction and suppressed the release of mast cell or basophil mediators from the IgE-treated hPCLS. In contrast, SYKi had little effect on the non-allergic contraction induced by carbachol. Syk mRNA and protein were undetectable in HASM cells.A selective Syk inhibitor, but not corticosteroids, abolished FcεR-mediated contraction in human small airways ex vivo. The mechanism involved FcεRI receptor activation on mast cells or basophils that degranulate causing airway constriction, rather than direct actions on HASM.

PubMed ID: 27417329 Exiting the NIEHS site

MeSH Terms: Cells, Cultured; Humans; Immunoglobulin E/immunology*; In Vitro Techniques; Lung/cytology; Lung/drug effects*; Lung/enzymology; Lung/immunology; Muscle Contraction/drug effects; Muscle Contraction/immunology; Muscle, Smooth/drug effects*; Muscle, Smooth/enzymology; Muscle, Smooth/immunology; Protein Kinase Inhibitors/chemistry; Protein Kinase Inhibitors/pharmacology*; Protein-Tyrosine Kinases/antagonists & inhibitors*; Protein-Tyrosine Kinases/metabolism; Spleen/enzymology*

to Top